Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT02581150
Eligibility Criteria:
Inclusion Criteria:
* Patients limping
* Patients with PAD requiring endovascular management
* Patients with stabilized level 1 to 3 ASA (classification of the American Society of Anesthesiology)
* Ability to walking
* Endovascular indicated and compatible with an introducer 5F to 7F
* Agreeing to participate in the study and having signed an informed consent.
* Agreeing to lend itself to a post-operative monitoring a duration of 30 days
* Social Insured
Exclusion Criteria:
* No possibility of an outpatient management
* Previous participation in the AMBUVASC study
* Refusal of patient to participate in the study
* Patient with hemostasis disorders
* Acute Ischemia
* Using a more 7F introducer
* Radial or brachial puncture
* Antegrade femoral puncture
* Contraindication to endovascular treatment
* Less than one month life expectancy
* Participation in another clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT02581150
Study Brief:
Protocol Section:
NCT02581150